mirror of
https://github.com/italia/covid19-opendata-vaccini
synced 2024-11-18 02:19:55 +01:00
40 KiB
40 KiB
1 | data | forn | area | eta | m | f | d1 | d2 | dpi | db1 | db2 | db3 | N1 | N2 | ISTAT | reg |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 2020-12-27 | Moderna | LAZ | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
3 | 2020-12-27 | Moderna | SIC | 90+ | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
4 | 2020-12-27 | Pfizer/BioNTech | ABR | 20-29 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
5 | 2020-12-27 | Pfizer/BioNTech | ABR | 30-39 | 1.0 | 4.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
6 | 2020-12-27 | Pfizer/BioNTech | ABR | 40-49 | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
7 | 2020-12-27 | Pfizer/BioNTech | ABR | 50-59 | 7.0 | 6.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
8 | 2020-12-27 | Pfizer/BioNTech | ABR | 60-69 | 12.0 | 4.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
9 | 2020-12-27 | Pfizer/BioNTech | ABR | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
10 | 2020-12-27 | Pfizer/BioNTech | ABR | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
11 | 2020-12-27 | Pfizer/BioNTech | BAS | 20-29 | 4.0 | 5.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
12 | 2020-12-27 | Pfizer/BioNTech | BAS | 30-39 | 10.0 | 18.0 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
13 | 2020-12-27 | Pfizer/BioNTech | BAS | 40-49 | 7.0 | 24.0 | 31.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
14 | 2020-12-27 | Pfizer/BioNTech | BAS | 50-59 | 11.0 | 15.0 | 26.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
15 | 2020-12-27 | Pfizer/BioNTech | BAS | 60-69 | 9.0 | 4.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
16 | 2020-12-27 | Pfizer/BioNTech | CAL | 20-29 | 18.0 | 42.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
17 | 2020-12-27 | Pfizer/BioNTech | CAL | 30-39 | 25.0 | 25.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
18 | 2020-12-27 | Pfizer/BioNTech | CAL | 40-49 | 25.0 | 32.0 | 57.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
19 | 2020-12-27 | Pfizer/BioNTech | CAL | 50-59 | 57.0 | 31.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
20 | 2020-12-27 | Pfizer/BioNTech | CAL | 60-69 | 46.0 | 18.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
21 | 2020-12-27 | Pfizer/BioNTech | CAM | 20-29 | 27.0 | 33.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
22 | 2020-12-27 | Pfizer/BioNTech | CAM | 30-39 | 61.0 | 64.0 | 125.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
23 | 2020-12-27 | Pfizer/BioNTech | CAM | 40-49 | 80.0 | 87.0 | 167.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
24 | 2020-12-27 | Pfizer/BioNTech | CAM | 50-59 | 119.0 | 77.0 | 196.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
25 | 2020-12-27 | Pfizer/BioNTech | CAM | 60-69 | 131.0 | 37.0 | 167.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
26 | 2020-12-27 | Pfizer/BioNTech | CAM | 70-79 | 5.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
27 | 2020-12-27 | Pfizer/BioNTech | EMR | 20-29 | 53.0 | 86.0 | 139.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
28 | 2020-12-27 | Pfizer/BioNTech | EMR | 30-39 | 58.0 | 83.0 | 141.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
29 | 2020-12-27 | Pfizer/BioNTech | EMR | 40-49 | 80.0 | 148.0 | 228.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
30 | 2020-12-27 | Pfizer/BioNTech | EMR | 50-59 | 71.0 | 217.0 | 288.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
31 | 2020-12-27 | Pfizer/BioNTech | EMR | 60-69 | 100.0 | 51.0 | 151.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
32 | 2020-12-27 | Pfizer/BioNTech | EMR | 70-79 | 10.0 | 3.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
33 | 2020-12-27 | Pfizer/BioNTech | EMR | 80-89 | 2.0 | 6.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
34 | 2020-12-27 | Pfizer/BioNTech | EMR | 90+ | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
35 | 2020-12-27 | Pfizer/BioNTech | FVG | 20-29 | 1.0 | 4.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
36 | 2020-12-27 | Pfizer/BioNTech | FVG | 30-39 | 9.0 | 7.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
37 | 2020-12-27 | Pfizer/BioNTech | FVG | 40-49 | 17.0 | 33.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
38 | 2020-12-27 | Pfizer/BioNTech | FVG | 50-59 | 59.0 | 46.0 | 105.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
39 | 2020-12-27 | Pfizer/BioNTech | FVG | 60-69 | 62.0 | 23.0 | 85.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
40 | 2020-12-27 | Pfizer/BioNTech | FVG | 70-79 | 3.0 | 2.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
41 | 2020-12-27 | Pfizer/BioNTech | LAZ | 20-29 | 32.0 | 32.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
42 | 2020-12-27 | Pfizer/BioNTech | LAZ | 30-39 | 39.0 | 41.0 | 80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
43 | 2020-12-27 | Pfizer/BioNTech | LAZ | 40-49 | 20.0 | 33.0 | 52.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
44 | 2020-12-27 | Pfizer/BioNTech | LAZ | 50-59 | 26.0 | 30.0 | 56.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
45 | 2020-12-27 | Pfizer/BioNTech | LAZ | 60-69 | 16.0 | 8.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
46 | 2020-12-27 | Pfizer/BioNTech | LIG | 20-29 | 6.0 | 3.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
47 | 2020-12-27 | Pfizer/BioNTech | LIG | 30-39 | 10.0 | 14.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
48 | 2020-12-27 | Pfizer/BioNTech | LIG | 40-49 | 6.0 | 14.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
49 | 2020-12-27 | Pfizer/BioNTech | LIG | 50-59 | 16.0 | 19.0 | 35.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
50 | 2020-12-27 | Pfizer/BioNTech | LIG | 60-69 | 13.0 | 4.0 | 16.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
51 | 2020-12-27 | Pfizer/BioNTech | LIG | 70-79 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
52 | 2020-12-27 | Pfizer/BioNTech | LIG | 80-89 | 2.0 | 10.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
53 | 2020-12-27 | Pfizer/BioNTech | LIG | 90+ | 1.0 | 12.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
54 | 2020-12-27 | Pfizer/BioNTech | LOM | 20-29 | 20.0 | 22.0 | 42.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
55 | 2020-12-27 | Pfizer/BioNTech | LOM | 30-39 | 31.0 | 33.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
56 | 2020-12-27 | Pfizer/BioNTech | LOM | 40-49 | 62.0 | 81.0 | 142.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
57 | 2020-12-27 | Pfizer/BioNTech | LOM | 50-59 | 115.0 | 119.0 | 234.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
58 | 2020-12-27 | Pfizer/BioNTech | LOM | 60-69 | 160.0 | 41.0 | 201.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
59 | 2020-12-27 | Pfizer/BioNTech | LOM | 70-79 | 21.0 | 2.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
60 | 2020-12-27 | Pfizer/BioNTech | LOM | 80-89 | 4.0 | 6.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
61 | 2020-12-27 | Pfizer/BioNTech | LOM | 90+ | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
62 | 2020-12-27 | Pfizer/BioNTech | MAR | 30-39 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
63 | 2020-12-27 | Pfizer/BioNTech | MAR | 40-49 | 3.0 | 8.0 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
64 | 2020-12-27 | Pfizer/BioNTech | MAR | 50-59 | 8.0 | 15.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
65 | 2020-12-27 | Pfizer/BioNTech | MAR | 60-69 | 9.0 | 4.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
66 | 2020-12-27 | Pfizer/BioNTech | MAR | 70-79 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
67 | 2020-12-27 | Pfizer/BioNTech | MAR | 80-89 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
68 | 2020-12-27 | Pfizer/BioNTech | MAR | 90+ | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
69 | 2020-12-27 | Pfizer/BioNTech | MOL | 20-29 | 0.0 | 4.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
70 | 2020-12-27 | Pfizer/BioNTech | MOL | 30-39 | 4.0 | 5.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
71 | 2020-12-27 | Pfizer/BioNTech | MOL | 40-49 | 4.0 | 3.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
72 | 2020-12-27 | Pfizer/BioNTech | MOL | 50-59 | 5.0 | 5.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
73 | 2020-12-27 | Pfizer/BioNTech | MOL | 60-69 | 4.0 | 0.0 | 3.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
74 | 2020-12-27 | Pfizer/BioNTech | MOL | 70-79 | 1.0 | 3.0 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
75 | 2020-12-27 | Pfizer/BioNTech | MOL | 80-89 | 0.0 | 6.0 | 5.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
76 | 2020-12-27 | Pfizer/BioNTech | MOL | 90+ | 2.0 | 4.0 | 4.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
77 | 2020-12-27 | Pfizer/BioNTech | PAB | 20-29 | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
78 | 2020-12-27 | Pfizer/BioNTech | PAB | 30-39 | 10.0 | 10.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
79 | 2020-12-27 | Pfizer/BioNTech | PAB | 40-49 | 18.0 | 28.0 | 46.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
80 | 2020-12-27 | Pfizer/BioNTech | PAB | 50-59 | 26.0 | 28.0 | 54.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
81 | 2020-12-27 | Pfizer/BioNTech | PAB | 60-69 | 9.0 | 7.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
82 | 2020-12-27 | Pfizer/BioNTech | PAB | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
83 | 2020-12-27 | Pfizer/BioNTech | PAB | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
84 | 2020-12-27 | Pfizer/BioNTech | PAT | 20-29 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
85 | 2020-12-27 | Pfizer/BioNTech | PAT | 30-39 | 2.0 | 7.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
86 | 2020-12-27 | Pfizer/BioNTech | PAT | 40-49 | 8.0 | 17.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
87 | 2020-12-27 | Pfizer/BioNTech | PAT | 50-59 | 10.0 | 19.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
88 | 2020-12-27 | Pfizer/BioNTech | PAT | 60-69 | 16.0 | 6.0 | 22.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
89 | 2020-12-27 | Pfizer/BioNTech | PAT | 70-79 | 3.0 | 1.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
90 | 2020-12-27 | Pfizer/BioNTech | PAT | 80-89 | 1.0 | 7.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
91 | 2020-12-27 | Pfizer/BioNTech | PAT | 90+ | 1.0 | 5.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
92 | 2020-12-27 | Pfizer/BioNTech | PIE | 20-29 | 25.0 | 63.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
93 | 2020-12-27 | Pfizer/BioNTech | PIE | 30-39 | 61.0 | 85.0 | 146.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
94 | 2020-12-27 | Pfizer/BioNTech | PIE | 40-49 | 68.0 | 135.0 | 203.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
95 | 2020-12-27 | Pfizer/BioNTech | PIE | 50-59 | 105.0 | 191.0 | 294.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
96 | 2020-12-27 | Pfizer/BioNTech | PIE | 60-69 | 94.0 | 37.0 | 131.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
97 | 2020-12-27 | Pfizer/BioNTech | PIE | 70-79 | 9.0 | 10.0 | 19.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
98 | 2020-12-27 | Pfizer/BioNTech | PIE | 80-89 | 5.0 | 19.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
99 | 2020-12-27 | Pfizer/BioNTech | PIE | 90+ | 5.0 | 15.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
100 | 2020-12-27 | Pfizer/BioNTech | PUG | 20-29 | 18.0 | 34.0 | 52.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
101 | 2020-12-27 | Pfizer/BioNTech | PUG | 30-39 | 32.0 | 54.0 | 86.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
102 | 2020-12-27 | Pfizer/BioNTech | PUG | 40-49 | 35.0 | 43.0 | 78.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
103 | 2020-12-27 | Pfizer/BioNTech | PUG | 50-59 | 69.0 | 62.0 | 131.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
104 | 2020-12-27 | Pfizer/BioNTech | PUG | 60-69 | 80.0 | 20.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
105 | 2020-12-27 | Pfizer/BioNTech | PUG | 70-79 | 9.0 | 8.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
106 | 2020-12-27 | Pfizer/BioNTech | PUG | 80-89 | 6.0 | 23.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
107 | 2020-12-27 | Pfizer/BioNTech | PUG | 90+ | 3.0 | 14.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
108 | 2020-12-27 | Pfizer/BioNTech | SAR | 20-29 | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
109 | 2020-12-27 | Pfizer/BioNTech | SAR | 30-39 | 0.0 | 3.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
110 | 2020-12-27 | Pfizer/BioNTech | SAR | 40-49 | 3.0 | 7.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
111 | 2020-12-27 | Pfizer/BioNTech | SAR | 50-59 | 12.0 | 8.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
112 | 2020-12-27 | Pfizer/BioNTech | SAR | 60-69 | 21.0 | 8.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
113 | 2020-12-27 | Pfizer/BioNTech | SAR | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
114 | 2020-12-27 | Pfizer/BioNTech | SIC | 20-29 | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
115 | 2020-12-27 | Pfizer/BioNTech | SIC | 30-39 | 7.0 | 9.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
116 | 2020-12-27 | Pfizer/BioNTech | SIC | 40-49 | 16.0 | 9.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
117 | 2020-12-27 | Pfizer/BioNTech | SIC | 50-59 | 22.0 | 8.0 | 30.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
118 | 2020-12-27 | Pfizer/BioNTech | SIC | 60-69 | 38.0 | 10.0 | 48.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
119 | 2020-12-27 | Pfizer/BioNTech | SIC | 70-79 | 10.0 | 4.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
120 | 2020-12-27 | Pfizer/BioNTech | SIC | 80-89 | 2.0 | 7.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
121 | 2020-12-27 | Pfizer/BioNTech | SIC | 90+ | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
122 | 2020-12-27 | Pfizer/BioNTech | TOS | 20-29 | 21.0 | 29.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
123 | 2020-12-27 | Pfizer/BioNTech | TOS | 30-39 | 51.0 | 64.0 | 115.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
124 | 2020-12-27 | Pfizer/BioNTech | TOS | 40-49 | 53.0 | 99.0 | 152.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
125 | 2020-12-27 | Pfizer/BioNTech | TOS | 50-59 | 73.0 | 114.0 | 187.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
126 | 2020-12-27 | Pfizer/BioNTech | TOS | 60-69 | 67.0 | 41.0 | 107.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
127 | 2020-12-27 | Pfizer/BioNTech | TOS | 70-79 | 8.0 | 1.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
128 | 2020-12-27 | Pfizer/BioNTech | TOS | 80-89 | 2.0 | 1.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
129 | 2020-12-27 | Pfizer/BioNTech | TOS | 90+ | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
130 | 2020-12-27 | Pfizer/BioNTech | UMB | 20-29 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
131 | 2020-12-27 | Pfizer/BioNTech | UMB | 30-39 | 8.0 | 2.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
132 | 2020-12-27 | Pfizer/BioNTech | UMB | 40-49 | 4.0 | 10.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
133 | 2020-12-27 | Pfizer/BioNTech | UMB | 50-59 | 10.0 | 15.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
134 | 2020-12-27 | Pfizer/BioNTech | UMB | 60-69 | 24.0 | 6.0 | 30.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
135 | 2020-12-27 | Pfizer/BioNTech | UMB | 70-79 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
136 | 2020-12-27 | Pfizer/BioNTech | UMB | 80-89 | 1.0 | 5.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
137 | 2020-12-27 | Pfizer/BioNTech | UMB | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
138 | 2020-12-27 | Pfizer/BioNTech | VDA | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
139 | 2020-12-27 | Pfizer/BioNTech | VDA | 30-39 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
140 | 2020-12-27 | Pfizer/BioNTech | VDA | 40-49 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
141 | 2020-12-27 | Pfizer/BioNTech | VDA | 50-59 | 4.0 | 5.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
142 | 2020-12-27 | Pfizer/BioNTech | VDA | 60-69 | 3.0 | 2.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
143 | 2020-12-27 | Pfizer/BioNTech | VEN | 20-29 | 22.0 | 53.0 | 68.0 | 0.0 | 7.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
144 | 2020-12-27 | Pfizer/BioNTech | VEN | 30-39 | 62.0 | 57.0 | 117.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
145 | 2020-12-27 | Pfizer/BioNTech | VEN | 40-49 | 51.0 | 105.0 | 156.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
146 | 2020-12-27 | Pfizer/BioNTech | VEN | 50-59 | 121.0 | 217.0 | 338.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
147 | 2020-12-27 | Pfizer/BioNTech | VEN | 60-69 | 133.0 | 51.0 | 182.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
148 | 2020-12-27 | Pfizer/BioNTech | VEN | 70-79 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
149 | 2020-12-28 | Moderna | FVG | 30-39 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
150 | 2020-12-28 | Moderna | LAZ | 20-29 | 1.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
151 | 2020-12-28 | Moderna | LAZ | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
152 | 2020-12-28 | Pfizer/BioNTech | CAL | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
153 | 2020-12-28 | Pfizer/BioNTech | CAL | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
154 | 2020-12-28 | Pfizer/BioNTech | CAL | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
155 | 2020-12-28 | Pfizer/BioNTech | CAL | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
156 | 2020-12-28 | Pfizer/BioNTech | CAL | 60-69 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
157 | 2020-12-28 | Pfizer/BioNTech | EMR | 40-49 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
158 | 2020-12-28 | Pfizer/BioNTech | LAZ | 20-29 | 58.0 | 67.0 | 125.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
159 | 2020-12-28 | Pfizer/BioNTech | LAZ | 30-39 | 86.0 | 89.0 | 175.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
160 | 2020-12-28 | Pfizer/BioNTech | LAZ | 40-49 | 63.0 | 175.0 | 238.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
161 | 2020-12-28 | Pfizer/BioNTech | LAZ | 50-59 | 110.0 | 173.0 | 283.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
162 | 2020-12-28 | Pfizer/BioNTech | LAZ | 60-69 | 97.0 | 47.0 | 144.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
163 | 2020-12-28 | Pfizer/BioNTech | LIG | 20-29 | 1.0 | 4.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
164 | 2020-12-28 | Pfizer/BioNTech | LIG | 30-39 | 4.0 | 9.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
165 | 2020-12-28 | Pfizer/BioNTech | LIG | 40-49 | 9.0 | 14.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
166 | 2020-12-28 | Pfizer/BioNTech | LIG | 50-59 | 10.0 | 19.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
167 | 2020-12-28 | Pfizer/BioNTech | LIG | 60-69 | 5.0 | 5.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
168 | 2020-12-28 | Pfizer/BioNTech | LIG | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
169 | 2020-12-28 | Pfizer/BioNTech | LOM | 20-29 | 3.0 | 4.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
170 | 2020-12-28 | Pfizer/BioNTech | LOM | 30-39 | 9.0 | 11.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
171 | 2020-12-28 | Pfizer/BioNTech | LOM | 40-49 | 9.0 | 20.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
172 | 2020-12-28 | Pfizer/BioNTech | LOM | 50-59 | 18.0 | 20.0 | 38.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
173 | 2020-12-28 | Pfizer/BioNTech | LOM | 60-69 | 8.0 | 6.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
174 | 2020-12-28 | Pfizer/BioNTech | SAR | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
175 | 2020-12-28 | Pfizer/BioNTech | SAR | 30-39 | 4.0 | 2.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
176 | 2020-12-28 | Pfizer/BioNTech | SAR | 40-49 | 8.0 | 12.0 | 19.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
177 | 2020-12-28 | Pfizer/BioNTech | SAR | 50-59 | 9.0 | 15.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
178 | 2020-12-28 | Pfizer/BioNTech | SAR | 60-69 | 6.0 | 12.0 | 18.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
179 | 2020-12-28 | Pfizer/BioNTech | SIC | 20-29 | 17.0 | 17.0 | 34.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
180 | 2020-12-28 | Pfizer/BioNTech | SIC | 30-39 | 36.0 | 24.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
181 | 2020-12-28 | Pfizer/BioNTech | SIC | 40-49 | 29.0 | 29.0 | 58.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
182 | 2020-12-28 | Pfizer/BioNTech | SIC | 50-59 | 37.0 | 16.0 | 53.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
183 | 2020-12-28 | Pfizer/BioNTech | SIC | 60-69 | 46.0 | 18.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
184 | 2020-12-28 | Pfizer/BioNTech | SIC | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
185 | 2020-12-28 | Pfizer/BioNTech | TOS | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
186 | 2020-12-29 | Moderna | FVG | 30-39 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
187 | 2020-12-29 | Moderna | LAZ | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
188 | 2020-12-29 | Moderna | LAZ | 40-49 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
189 | 2020-12-29 | Moderna | LAZ | 50-59 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
190 | 2020-12-29 | Pfizer/BioNTech | LAZ | 20-29 | 9.0 | 41.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
191 | 2020-12-29 | Pfizer/BioNTech | LAZ | 30-39 | 31.0 | 49.0 | 80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
192 | 2020-12-29 | Pfizer/BioNTech | LAZ | 40-49 | 26.0 | 76.0 | 102.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
193 | 2020-12-29 | Pfizer/BioNTech | LAZ | 50-59 | 60.0 | 121.0 | 181.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
194 | 2020-12-29 | Pfizer/BioNTech | LAZ | 60-69 | 58.0 | 30.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
195 | 2020-12-29 | Pfizer/BioNTech | LAZ | 70-79 | 3.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
196 | 2020-12-29 | Pfizer/BioNTech | LIG | 20-29 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
197 | 2020-12-29 | Pfizer/BioNTech | LIG | 30-39 | 9.0 | 19.0 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
198 | 2020-12-29 | Pfizer/BioNTech | LIG | 40-49 | 5.0 | 18.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
199 | 2020-12-29 | Pfizer/BioNTech | LIG | 50-59 | 8.0 | 29.0 | 37.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
200 | 2020-12-29 | Pfizer/BioNTech | LIG | 60-69 | 6.0 | 6.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
201 | 2020-12-29 | Pfizer/BioNTech | LIG | 70-79 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
202 | 2020-12-29 | Pfizer/BioNTech | LIG | 80-89 | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
203 | 2020-12-29 | Pfizer/BioNTech | LIG | 90+ | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
204 | 2020-12-29 | Pfizer/BioNTech | LOM | 20-29 | 2.0 | 9.0 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
205 | 2020-12-29 | Pfizer/BioNTech | LOM | 30-39 | 16.0 | 15.0 | 31.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
206 | 2020-12-29 | Pfizer/BioNTech | LOM | 40-49 | 10.0 | 18.0 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
207 | 2020-12-29 | Pfizer/BioNTech | LOM | 50-59 | 9.0 | 16.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
208 | 2020-12-29 | Pfizer/BioNTech | LOM | 60-69 | 8.0 | 4.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
209 | 2020-12-29 | Pfizer/BioNTech | PUG | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
210 | 2020-12-29 | Pfizer/BioNTech | SAR | 20-29 | 2.0 | 2.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
211 | 2020-12-29 | Pfizer/BioNTech | SAR | 30-39 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
212 | 2020-12-29 | Pfizer/BioNTech | SAR | 40-49 | 7.0 | 5.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
213 | 2020-12-29 | Pfizer/BioNTech | SAR | 50-59 | 10.0 | 11.0 | 21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
214 | 2020-12-29 | Pfizer/BioNTech | SAR | 60-69 | 12.0 | 5.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
215 | 2020-12-29 | Pfizer/BioNTech | SIC | 20-29 | 12.0 | 8.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
216 | 2020-12-29 | Pfizer/BioNTech | SIC | 30-39 | 34.0 | 35.0 | 68.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
217 | 2020-12-29 | Pfizer/BioNTech | SIC | 40-49 | 44.0 | 28.0 | 72.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
218 | 2020-12-29 | Pfizer/BioNTech | SIC | 50-59 | 40.0 | 26.0 | 66.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
219 | 2020-12-29 | Pfizer/BioNTech | SIC | 60-69 | 55.0 | 17.0 | 72.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
220 | 2020-12-29 | Pfizer/BioNTech | TOS | 40-49 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
221 | 2020-12-30 | Moderna | FVG | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
222 | 2020-12-30 | Moderna | FVG | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
223 | 2020-12-30 | Moderna | FVG | 30-39 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
224 | 2020-12-30 | Moderna | FVG | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
225 | 2020-12-30 | Moderna | LAZ | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
226 | 2020-12-30 | Moderna | LAZ | 30-39 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
227 | 2020-12-30 | Moderna | LAZ | 40-49 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
228 | 2020-12-30 | Moderna | LAZ | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
229 | 2020-12-30 | Pfizer/BioNTech | EMR | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
230 | 2020-12-30 | Pfizer/BioNTech | EMR | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
231 | 2020-12-30 | Pfizer/BioNTech | FVG | 20-29 | 18.0 | 33.0 | 51.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
232 | 2020-12-30 | Pfizer/BioNTech | FVG | 30-39 | 55.0 | 82.0 | 137.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
233 | 2020-12-30 | Pfizer/BioNTech | FVG | 40-49 | 46.0 | 119.0 | 165.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
234 | 2020-12-30 | Pfizer/BioNTech | FVG | 50-59 | 60.0 | 110.0 | 170.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
235 | 2020-12-30 | Pfizer/BioNTech | FVG | 60-69 | 54.0 | 40.0 | 94.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
236 | 2020-12-30 | Pfizer/BioNTech | FVG | 70-79 | 13.0 | 2.0 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
237 | 2020-12-30 | Pfizer/BioNTech | FVG | 80-89 | 2.0 | 1.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
238 | 2020-12-30 | Pfizer/BioNTech | LAZ | 20-29 | 58.0 | 90.0 | 148.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
239 | 2020-12-30 | Pfizer/BioNTech | LAZ | 30-39 | 122.0 | 211.0 | 333.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
240 | 2020-12-30 | Pfizer/BioNTech | LAZ | 40-49 | 148.0 | 300.0 | 448.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
241 | 2020-12-30 | Pfizer/BioNTech | LAZ | 50-59 | 158.0 | 284.0 | 442.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
242 | 2020-12-30 | Pfizer/BioNTech | LAZ | 60-69 | 131.0 | 86.0 | 217.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
243 | 2020-12-30 | Pfizer/BioNTech | LAZ | 70-79 | 17.0 | 16.0 | 33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
244 | 2020-12-30 | Pfizer/BioNTech | LAZ | 80-89 | 6.0 | 23.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
245 | 2020-12-30 | Pfizer/BioNTech | LAZ | 90+ | 1.0 | 12.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
246 | 2020-12-30 | Pfizer/BioNTech | LIG | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
247 | 2020-12-30 | Pfizer/BioNTech | LIG | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
248 | 2020-12-30 | Pfizer/BioNTech | LIG | 40-49 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
249 | 2020-12-30 | Pfizer/BioNTech | LIG | 50-59 | 4.0 | 3.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
250 | 2020-12-30 | Pfizer/BioNTech | LIG | 60-69 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
251 | 2020-12-30 | Pfizer/BioNTech | LOM | 20-29 | 3.0 | 9.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
252 | 2020-12-30 | Pfizer/BioNTech | LOM | 30-39 | 11.0 | 25.0 | 36.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
253 | 2020-12-30 | Pfizer/BioNTech | LOM | 40-49 | 10.0 | 16.0 | 26.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
254 | 2020-12-30 | Pfizer/BioNTech | LOM | 50-59 | 13.0 | 21.0 | 34.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
255 | 2020-12-30 | Pfizer/BioNTech | LOM | 60-69 | 4.0 | 2.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
256 | 2020-12-30 | Pfizer/BioNTech | LOM | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
257 | 2020-12-30 | Pfizer/BioNTech | MAR | 20-29 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
258 | 2020-12-30 | Pfizer/BioNTech | MAR | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
259 | 2020-12-30 | Pfizer/BioNTech | MAR | 40-49 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
260 | 2020-12-30 | Pfizer/BioNTech | MAR | 50-59 | 2.0 | 6.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
261 | 2020-12-30 | Pfizer/BioNTech | MAR | 60-69 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
262 | 2020-12-30 | Pfizer/BioNTech | PAB | 20-29 | 22.0 | 33.0 | 54.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
263 | 2020-12-30 | Pfizer/BioNTech | PAB | 30-39 | 36.0 | 31.0 | 66.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
264 | 2020-12-30 | Pfizer/BioNTech | PAB | 40-49 | 55.0 | 88.0 | 143.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
265 | 2020-12-30 | Pfizer/BioNTech | PAB | 50-59 | 54.0 | 50.0 | 104.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
266 | 2020-12-30 | Pfizer/BioNTech | PAB | 60-69 | 29.0 | 12.0 | 41.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
267 | 2020-12-30 | Pfizer/BioNTech | PAB | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
268 | 2020-12-30 | Pfizer/BioNTech | PAT | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
269 | 2020-12-30 | Pfizer/BioNTech | PAT | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
270 | 2020-12-30 | Pfizer/BioNTech | PAT | 60-69 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
271 | 2020-12-30 | Pfizer/BioNTech | PAT | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
272 | 2020-12-30 | Pfizer/BioNTech | PAT | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
273 | 2020-12-30 | Pfizer/BioNTech | PAT | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
274 | 2020-12-30 | Pfizer/BioNTech | PIE | 20-29 | 49.0 | 84.0 | 133.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
275 | 2020-12-30 | Pfizer/BioNTech | PIE | 30-39 | 65.0 | 44.0 | 109.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
276 | 2020-12-30 | Pfizer/BioNTech | PIE | 40-49 | 79.0 | 108.0 | 187.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
277 | 2020-12-30 | Pfizer/BioNTech | PIE | 50-59 | 80.0 | 145.0 | 225.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
278 | 2020-12-30 | Pfizer/BioNTech | PIE | 60-69 | 56.0 | 47.0 | 103.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
279 | 2020-12-30 | Pfizer/BioNTech | PUG | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
280 | 2020-12-30 | Pfizer/BioNTech | SIC | 20-29 | 15.0 | 12.0 | 27.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
281 | 2020-12-30 | Pfizer/BioNTech | SIC | 30-39 | 32.0 | 31.0 | 63.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
282 | 2020-12-30 | Pfizer/BioNTech | SIC | 40-49 | 29.0 | 21.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
283 | 2020-12-30 | Pfizer/BioNTech | SIC | 50-59 | 41.0 | 14.0 | 55.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
284 | 2020-12-30 | Pfizer/BioNTech | SIC | 60-69 | 24.0 | 14.0 | 38.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
285 | 2020-12-30 | Pfizer/BioNTech | TOS | 12-19 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
286 | 2020-12-30 | Pfizer/BioNTech | TOS | 20-29 | 9.0 | 3.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
287 | 2020-12-30 | Pfizer/BioNTech | TOS | 30-39 | 7.0 | 9.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
288 | 2020-12-30 | Pfizer/BioNTech | TOS | 40-49 | 5.0 | 18.0 | 22.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
289 | 2020-12-30 | Pfizer/BioNTech | TOS | 50-59 | 15.0 | 20.0 | 35.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
290 | 2020-12-30 | Pfizer/BioNTech | TOS | 60-69 | 11.0 | 9.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
291 | 2020-12-30 | Pfizer/BioNTech | TOS | 70-79 | 20.0 | 16.0 | 36.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
292 | 2020-12-30 | Pfizer/BioNTech | TOS | 80-89 | 24.0 | 84.0 | 108.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
293 | 2020-12-30 | Pfizer/BioNTech | TOS | 90+ | 11.0 | 65.0 | 76.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
294 | 2020-12-30 | Pfizer/BioNTech | VEN | 20-29 | 14.0 | 38.0 | 47.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
295 | 2020-12-30 | Pfizer/BioNTech | VEN | 30-39 | 46.0 | 76.0 | 115.0 | 0.0 | 7.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
296 | 2020-12-30 | Pfizer/BioNTech | VEN | 40-49 | 57.0 | 144.0 | 197.0 | 0.0 | 4.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
297 | 2020-12-30 | Pfizer/BioNTech | VEN | 50-59 | 66.0 | 150.0 | 212.0 | 0.0 | 4.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
298 | 2020-12-30 | Pfizer/BioNTech | VEN | 60-69 | 46.0 | 27.0 | 72.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
299 | 2020-12-30 | Pfizer/BioNTech | VEN | 70-79 | 4.0 | 4.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
300 | 2020-12-30 | Pfizer/BioNTech | VEN | 80-89 | 10.0 | 10.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
301 | 2020-12-30 | Pfizer/BioNTech | VEN | 90+ | 2.0 | 5.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
302 | 2020-12-31 | Pfizer/BioNTech | CAM | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
303 | 2020-12-31 | Pfizer/BioNTech | CAM | 20-29 | 48.0 | 78.0 | 126.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
304 | 2020-12-31 | Pfizer/BioNTech | CAM | 30-39 | 127.0 | 147.0 | 274.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
305 | 2020-12-31 | Pfizer/BioNTech | CAM | 40-49 | 171.0 | 182.0 | 352.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
306 | 2020-12-31 | Pfizer/BioNTech | CAM | 50-59 | 231.0 | 191.0 | 421.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
307 | 2020-12-31 | Pfizer/BioNTech | CAM | 60-69 | 229.0 | 79.0 | 307.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
308 | 2020-12-31 | Pfizer/BioNTech | CAM | 70-79 | 3.0 | 2.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
309 | 2020-12-31 | Pfizer/BioNTech | CAM | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
310 | 2020-12-31 | Pfizer/BioNTech | EMR | 20-29 | 67.0 | 174.0 | 241.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
311 | 2020-12-31 | Pfizer/BioNTech | EMR | 30-39 | 174.0 | 231.0 | 405.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
312 | 2020-12-31 | Pfizer/BioNTech | EMR | 40-49 | 151.0 | 311.0 | 460.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
313 | 2020-12-31 | Pfizer/BioNTech | EMR | 50-59 | 146.0 | 353.0 | 498.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
314 | 2020-12-31 | Pfizer/BioNTech | EMR | 60-69 | 183.0 | 115.0 | 298.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
315 | 2020-12-31 | Pfizer/BioNTech | EMR | 70-79 | 21.0 | 34.0 | 54.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
316 | 2020-12-31 | Pfizer/BioNTech | EMR | 80-89 | 25.0 | 121.0 | 144.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
317 | 2020-12-31 | Pfizer/BioNTech | EMR | 90+ | 15.0 | 102.0 | 116.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
318 | 2020-12-31 | Pfizer/BioNTech | FVG | 20-29 | 38.0 | 86.0 | 123.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
319 | 2020-12-31 | Pfizer/BioNTech | FVG | 30-39 | 90.0 | 133.0 | 223.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
320 | 2020-12-31 | Pfizer/BioNTech | FVG | 40-49 | 73.0 | 179.0 | 252.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
321 | 2020-12-31 | Pfizer/BioNTech | FVG | 50-59 | 83.0 | 212.0 | 295.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
322 | 2020-12-31 | Pfizer/BioNTech | FVG | 60-69 | 85.0 | 63.0 | 148.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
323 | 2020-12-31 | Pfizer/BioNTech | FVG | 70-79 | 15.0 | 2.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
324 | 2020-12-31 | Pfizer/BioNTech | FVG | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
325 | 2020-12-31 | Pfizer/BioNTech | FVG | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
326 | 2020-12-31 | Pfizer/BioNTech | LAZ | 20-29 | 138.0 | 297.0 | 435.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
327 | 2020-12-31 | Pfizer/BioNTech | LAZ | 30-39 | 405.0 | 569.0 | 974.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
328 | 2020-12-31 | Pfizer/BioNTech | LAZ | 40-49 | 423.0 | 892.0 | 1313.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
329 | 2020-12-31 | Pfizer/BioNTech | LAZ | 50-59 | 571.0 | 980.0 | 1548.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
330 | 2020-12-31 | Pfizer/BioNTech | LAZ | 60-69 | 561.0 | 328.0 | 887.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
331 | 2020-12-31 | Pfizer/BioNTech | LAZ | 70-79 | 33.0 | 32.0 | 65.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
332 | 2020-12-31 | Pfizer/BioNTech | LAZ | 80-89 | 27.0 | 81.0 | 108.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
333 | 2020-12-31 | Pfizer/BioNTech | LAZ | 90+ | 6.0 | 57.0 | 63.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
334 | 2020-12-31 | Pfizer/BioNTech | LIG | 20-29 | 19.0 | 54.0 | 73.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
335 | 2020-12-31 | Pfizer/BioNTech | LIG | 30-39 | 51.0 | 67.0 | 118.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
336 | 2020-12-31 | Pfizer/BioNTech | LIG | 40-49 | 39.0 | 129.0 | 168.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
337 | 2020-12-31 | Pfizer/BioNTech | LIG | 50-59 | 103.0 | 214.0 | 317.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
338 | 2020-12-31 | Pfizer/BioNTech | LIG | 60-69 | 93.0 | 49.0 | 141.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
339 | 2020-12-31 | Pfizer/BioNTech | LIG | 70-79 | 24.0 | 24.0 | 48.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
340 | 2020-12-31 | Pfizer/BioNTech | LIG | 80-89 | 15.0 | 58.0 | 73.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
341 | 2020-12-31 | Pfizer/BioNTech | LIG | 90+ | 8.0 | 43.0 | 51.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
342 | 2020-12-31 | Pfizer/BioNTech | LOM | 20-29 | 23.0 | 36.0 | 59.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
343 | 2020-12-31 | Pfizer/BioNTech | LOM | 30-39 | 76.0 | 84.0 | 160.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
344 | 2020-12-31 | Pfizer/BioNTech | LOM | 40-49 | 56.0 | 102.0 | 158.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
345 | 2020-12-31 | Pfizer/BioNTech | LOM | 50-59 | 88.0 | 161.0 | 249.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
346 | 2020-12-31 | Pfizer/BioNTech | LOM | 60-69 | 58.0 | 30.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
347 | 2020-12-31 | Pfizer/BioNTech | LOM | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
348 | 2020-12-31 | Pfizer/BioNTech | MAR | 20-29 | 6.0 | 9.0 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
349 | 2020-12-31 | Pfizer/BioNTech | MAR | 30-39 | 36.0 | 42.0 | 78.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
350 | 2020-12-31 | Pfizer/BioNTech | MAR | 40-49 | 44.0 | 66.0 | 110.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
351 | 2020-12-31 | Pfizer/BioNTech | MAR | 50-59 | 40.0 | 58.0 | 98.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
352 | 2020-12-31 | Pfizer/BioNTech | MAR | 60-69 | 59.0 | 34.0 | 93.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
353 | 2020-12-31 | Pfizer/BioNTech | PAB | 12-19 | 9.0 | 5.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
354 | 2020-12-31 | Pfizer/BioNTech | PAB | 20-29 | 66.0 | 55.0 | 121.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
355 | 2020-12-31 | Pfizer/BioNTech | PAB | 30-39 | 94.0 | 68.0 | 162.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
356 | 2020-12-31 | Pfizer/BioNTech | PAB | 40-49 | 123.0 | 103.0 | 225.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
357 | 2020-12-31 | Pfizer/BioNTech | PAB | 50-59 | 144.0 | 140.0 | 283.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
358 | 2020-12-31 | Pfizer/BioNTech | PAB | 60-69 | 81.0 | 29.0 | 110.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
359 | 2020-12-31 | Pfizer/BioNTech | PAB | 70-79 | 13.0 | 2.0 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
360 | 2020-12-31 | Pfizer/BioNTech | PAB | 80-89 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
361 | 2020-12-31 | Pfizer/BioNTech | PAT | 12-19 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
362 | 2020-12-31 | Pfizer/BioNTech | PAT | 20-29 | 32.0 | 92.0 | 124.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
363 | 2020-12-31 | Pfizer/BioNTech | PAT | 30-39 | 68.0 | 123.0 | 191.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
364 | 2020-12-31 | Pfizer/BioNTech | PAT | 40-49 | 55.0 | 216.0 | 271.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
365 | 2020-12-31 | Pfizer/BioNTech | PAT | 50-59 | 92.0 | 257.0 | 349.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
366 | 2020-12-31 | Pfizer/BioNTech | PAT | 60-69 | 81.0 | 86.0 | 167.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
367 | 2020-12-31 | Pfizer/BioNTech | PAT | 70-79 | 61.0 | 77.0 | 138.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
368 | 2020-12-31 | Pfizer/BioNTech | PAT | 80-89 | 76.0 | 204.0 | 279.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
369 | 2020-12-31 | Pfizer/BioNTech | PAT | 90+ | 21.0 | 190.0 | 211.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
370 | 2020-12-31 | Pfizer/BioNTech | PIE | 12-19 | 0.0 | 3.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
371 | 2020-12-31 | Pfizer/BioNTech | PIE | 20-29 | 119.0 | 251.0 | 369.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
372 | 2020-12-31 | Pfizer/BioNTech | PIE | 30-39 | 261.0 | 398.0 | 657.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
373 | 2020-12-31 | Pfizer/BioNTech | PIE | 40-49 | 264.0 | 700.0 | 963.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
374 | 2020-12-31 | Pfizer/BioNTech | PIE | 50-59 | 399.0 | 935.0 | 1331.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
375 | 2020-12-31 | Pfizer/BioNTech | PIE | 60-69 | 269.0 | 231.0 | 500.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
376 | 2020-12-31 | Pfizer/BioNTech | PIE | 70-79 | 19.0 | 16.0 | 35.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
377 | 2020-12-31 | Pfizer/BioNTech | PIE | 80-89 | 22.0 | 35.0 | 57.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
378 | 2020-12-31 | Pfizer/BioNTech | PIE | 90+ | 4.0 | 36.0 | 40.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
379 | 2020-12-31 | Pfizer/BioNTech | PUG | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
380 | 2020-12-31 | Pfizer/BioNTech | PUG | 20-29 | 72.0 | 132.0 | 204.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
381 | 2020-12-31 | Pfizer/BioNTech | PUG | 30-39 | 167.0 | 194.0 | 361.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
382 | 2020-12-31 | Pfizer/BioNTech | PUG | 40-49 | 190.0 | 232.0 | 422.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
383 | 2020-12-31 | Pfizer/BioNTech | PUG | 50-59 | 213.0 | 199.0 | 410.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
384 | 2020-12-31 | Pfizer/BioNTech | PUG | 60-69 | 130.0 | 65.0 | 195.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
385 | 2020-12-31 | Pfizer/BioNTech | PUG | 70-79 | 6.0 | 10.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
386 | 2020-12-31 | Pfizer/BioNTech | PUG | 80-89 | 8.0 | 11.0 | 19.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
387 | 2020-12-31 | Pfizer/BioNTech | PUG | 90+ | 0.0 | 10.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
388 | 2020-12-31 | Pfizer/BioNTech | SAR | 30-39 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
389 | 2020-12-31 | Pfizer/BioNTech | SAR | 40-49 | 3.0 | 3.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
390 | 2020-12-31 | Pfizer/BioNTech | SAR | 50-59 | 8.0 | 12.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
391 | 2020-12-31 | Pfizer/BioNTech | SAR | 60-69 | 8.0 | 1.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
392 | 2020-12-31 | Pfizer/BioNTech | SAR | 70-79 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
393 | 2020-12-31 | Pfizer/BioNTech | SIC | 12-19 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
394 | 2020-12-31 | Pfizer/BioNTech | SIC | 20-29 | 72.0 | 94.0 | 166.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
395 | 2020-12-31 | Pfizer/BioNTech | SIC | 30-39 | 87.0 | 93.0 | 179.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
396 | 2020-12-31 | Pfizer/BioNTech | SIC | 40-49 | 117.0 | 119.0 | 236.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
397 | 2020-12-31 | Pfizer/BioNTech | SIC | 50-59 | 147.0 | 116.0 | 263.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
398 | 2020-12-31 | Pfizer/BioNTech | SIC | 60-69 | 97.0 | 51.0 | 148.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
399 | 2020-12-31 | Pfizer/BioNTech | SIC | 70-79 | 6.0 | 0.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
400 | 2020-12-31 | Pfizer/BioNTech | TOS | 20-29 | 5.0 | 12.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
401 | 2020-12-31 | Pfizer/BioNTech | TOS | 30-39 | 11.0 | 16.0 | 27.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
402 | 2020-12-31 | Pfizer/BioNTech | TOS | 40-49 | 8.0 | 25.0 | 33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
403 | 2020-12-31 | Pfizer/BioNTech | TOS | 50-59 | 19.0 | 40.0 | 58.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
404 | 2020-12-31 | Pfizer/BioNTech | TOS | 60-69 | 25.0 | 47.0 | 72.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
405 | 2020-12-31 | Pfizer/BioNTech | TOS | 70-79 | 48.0 | 86.0 | 133.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
406 | 2020-12-31 | Pfizer/BioNTech | TOS | 80-89 | 60.0 | 198.0 | 258.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
407 | 2020-12-31 | Pfizer/BioNTech | TOS | 90+ | 26.0 | 179.0 | 203.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
408 | 2020-12-31 | Pfizer/BioNTech | UMB | 20-29 | 9.0 | 18.0 | 27.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
409 | 2020-12-31 | Pfizer/BioNTech | UMB | 30-39 | 26.0 | 37.0 | 63.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
410 | 2020-12-31 | Pfizer/BioNTech | UMB | 40-49 | 30.0 | 70.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
411 | 2020-12-31 | Pfizer/BioNTech | UMB | 50-59 | 35.0 | 73.0 | 108.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
412 | 2020-12-31 | Pfizer/BioNTech | UMB | 60-69 | 36.0 | 13.0 | 49.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
413 | 2020-12-31 | Pfizer/BioNTech | VDA | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
414 | 2020-12-31 | Pfizer/BioNTech | VDA | 30-39 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
415 | 2020-12-31 | Pfizer/BioNTech | VDA | 40-49 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
416 | 2020-12-31 | Pfizer/BioNTech | VDA | 50-59 | 3.0 | 7.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
417 | 2020-12-31 | Pfizer/BioNTech | VDA | 60-69 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
418 | 2020-12-31 | Pfizer/BioNTech | VEN | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
419 | 2020-12-31 | Pfizer/BioNTech | VEN | 20-29 | 93.0 | 255.0 | 313.0 | 0.0 | 35.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
420 | 2020-12-31 | Pfizer/BioNTech | VEN | 30-39 | 186.0 | 314.0 | 478.0 | 0.0 | 22.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
421 | 2020-12-31 | Pfizer/BioNTech | VEN | 40-49 | 201.0 | 562.0 | 743.0 | 0.0 | 20.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
422 | 2020-12-31 | Pfizer/BioNTech | VEN | 50-59 | 279.0 | 691.0 | 964.0 | 0.0 | 6.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
423 | 2020-12-31 | Pfizer/BioNTech | VEN | 60-69 | 234.0 | 162.0 | 393.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
424 | 2020-12-31 | Pfizer/BioNTech | VEN | 70-79 | 18.0 | 29.0 | 44.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
425 | 2020-12-31 | Pfizer/BioNTech | VEN | 80-89 | 24.0 | 74.0 | 97.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
426 | 2020-12-31 | Pfizer/BioNTech | VEN | 90+ | 6.0 | 92.0 | 97.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |